Boston Scientific Announces Results for Fourth Quarter and Year Ended Decembe...(p Acquisition and divestiture-related ...)

Acquisition and divestiture-related charges:

Loss on assets held for sale $208

Purchased research and development 13 2

Integration costs (a) (5) $19

Business optimization charges (b) 19

Step-up value of inventory sold ( c ) (12)

Fair-value adjustment for the sharing

of proceeds feature of the Abbott

Laboratories stock purchase (d) (5)

216 23

Income tax benefit (f) (5) -

Acquisition and divestiture-related

charges, net of tax $211 $23

Restructuring charges:

Restructuring charges (e) $184

Income tax benefit (f) (53)

Restructuring charges, net of tax $131

Litigation-related charges:

Litigation-related charges $365

Income tax benefit (f) (71)

Litigation-related charges, net of tax $294

Amortization expense:

Amortization expense $174 $174

Income tax expense (benefit) (f) 3 (32)

Amortization expense, net of tax $177 $142

(a) Recorded credits of $4 million in 2007 to selling, general and

administrative expenses and $1 million to research and development

expenses; recorded expenses of $2 million in 2006 to cost of

products sold, $7 million to selling, general and administrative

expenses and $10 million to research and development expenses.

(b) Recorded to selling, general and administrative expe
'/>"/>